Last reviewed · How we verify

NCT04369040: Ventinova ORL

Comparison of Two Ventilation Methods for Micro-Laryngeal Surgery

Terminated NA Last updated 4 April 2025
What this trial tests

NA trial testing High-flow nasal oxygen therapy using a specific nasal cannula in Laryngeal Disease in 3 participants. Terminated before completion.

Timeline
10 March 2022
Primary endpoint
11 July 2022
18 July 2022

Quick facts

Lead sponsorHopital Foch
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment3
Start date10 March 2022
Primary completion11 July 2022
Estimated completion18 July 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopital Foch — full company profile →

Who can join

Adults 18 to 80, female only, with Laryngeal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-center, randomized study, comparing two methods of oxygenation on 80 patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laryngeal Disease

Currently open trials in the same condition.

Other Hopital Foch trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04369040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing